At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Sep 9, 2026 at 16:02 ET
Four Artiva Biotherapeutics insiders, including the CEO, COO, CTO, and CMO, sold a total of $477K in open-market shares over a one-week window. The CEO's sale of $256K represents the largest portion. These sales occurred alongside a cluster of non-cash equity grants to the same executives, suggesting the sales are likely liquidity-driven to cover tax obligations from vesting awards, rather than a bearish signal on the company's prospects.
- CEO Fred Aslan sold 23,400 shares for $256K on 2026-09-08.
- COO Jennifer Bush sold 8,400 shares for $94K on 2026-09-03.
- CTO Christopher Horan sold 10,400 shares for $116K on 2026-09-03.
- CMO Subhashis Banerjee sold 1,100 shares for $12K on 2026-09-03.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access